Biography
Tadeusz Robak MD, Ph.D. is Professor of Hematology at the Medical university of Lodz, Poland. Professor Robak studied medicine at this institution and after graduating in 1973 went on to specialize in internal medicine, clinical pharmacology and hematology at the Copernicus Memorial Hospital in Lodz. He undertook further postgraduate training at Hammersmith Hospital, London, in 1983-1984. He currently holds the posts of Professor of Hematology at the Medical University of Lodz and Chief of Department of Hematology at the Copernicus Memorial Hospital in Lodz. Professor Robak is a reviewer for numerous journals including Journal of Clinical Oncology, Blood, Lancet, Lancet Oncology, Leukemia, Leukaemia and Lymphoma, Drugs, Drugs and Aging, BioDrugs, European Journal of Haematology, and other journals. He is current president of the Polish Society of Hematology and a member of European Hematology Association and American Society for Hematology.The particular research emphasis has been on the application of new drugs in the treatment of leukemia multiple myeloma and lymphoma and interactions of antineoplastic agents.
Research Interest
Dr. Tadeusz Robak's research interests include:
Chronic lymphocytic leukemia
Acute myeloid leukemia
Preclinical and clincal studies of nucleoside analogs and monoclonal antibodies in leukemia and lymphoma.
Related Publications
-
Evaluation of Anticoagulant and Antiplatelet Activity of Pisum sativum Pod Extract
Research Article: J Blood Res Hematol Dis 2017, 2:1
DOI:
Chethana Ramachandraiah, Sharath Kumar M Nandish, Jayanna Kengaiah, Ashwini Shivaiah, Chandramma, Kesturu S.Girish, Kempaiah Kemparaju and Devaraja Sannaningaiah
-
Haemophilia B PMS1 Gene SNPs Predictions through Insilico Approach at Proteomics Levels
Research Article: J Blood Res Hematol Dis 2017, 2:1
DOI:
Hiba Siddig Ibrahim
-
Optimal Therapy for Polycythemia Vera and Essential Thrombocythemia: A Different Perspective
Editorial: J Blood Res Hematol Dis 2015, 1:1
DOI:
Richard T Silver and Hans Carl Hasselbalch
-
Recent Advances in Hodgkin Lymphoma
Editorial: J Blood Res Hematol Dis 2016, 1:2
DOI:
Theodoros P Vassilakopoulos and Sotirios G Papageorgiou
-
Characterization of Complex Chromosomal Rearrangements in Acute Myeloid Leukemia: FISH and Multicolor FISH Add Precision in Defining Abnormalities Associated with Poor Prognosis
Research Article: J Blood Res Hematol Dis 2016, 1:2
DOI:
Pina J Trivedi, Dharmesh M Patel, Manisha M Brahmbhatt and Prabhudas S Patel
-
Caring for a Sick Child
Editorial: J Blood Res Hematol Dis 2016, 1:1
DOI:
Luisa M Massimo
-
Relationship between Cellular Senescence and Redox Potential on Adult T-Cell Leukemia Cells
Short Communication: J Blood Res Hematol Dis 2016, 1:1
DOI:
Yasuhiro Maeda, Atsushi Okamoto, Shin-ichiro Kawaguchi, Akiko Konishi, Kenta Yamamoto, Go Eguchi and Terufumi Yamaguchi
-
EHPVO and Splanchnic Vein Thrombosis
Review Article: J Blood Res Hematol Dis 2016, 1:2
DOI:
Afaq Ahmad Khan, Zeeshan Ahmad Wani, Tufeel Kochak and Sonmoon Mohapatra
-
Autoimmune Thyroid Disease in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms Treated with Interferon-Alpha
Research Article: J Blood Res Hematol Dis 2016, 1:1
DOI:
Cecilie Paulsrud, Hans C Hasselbalch and Ole Weis Bjerrum
-
Efficiency of Pre-Storage Leukoreduction of Red Cells: A Double Blind Quality Control Method, Transfusion medicine
Letter to Editor: J Blood Res Hematol Dis 2016, 1:2
DOI:
Setia Rasika, Arora Satyam, Handoo Anil and Kapoor Meenu
-
Timely Dosage Dependent Ethanolic Extract of Mangifera Indica Promotes Blood Cells Development and Weight Gain
Research Article: J Blood Res Hematol Dis 2016, 1:2
DOI:
Jimmy EO and Udo ES
-
The Role of Wnt/β -Catenin Signaling in Normal and Malignant Hematopoiesis, Hemostasis
Review Article: J Blood Res Hematol Dis 2016, 1:1
DOI:
Teresa Sadras, Richard J D’Andrea and Deborah L White